arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

OSR Health, Inc.

OSRH

$0.45 ▲ +0.01 (+2.65%) at close

6 Visible periods

28 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, OSR Health, Inc. shows weak fundamentals, weighed down by FCF Margin (%) and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $8.8M

Dividend Yield —

Revenue Growth -17.7%

Op. Margin None

ROIC None

FCF / Share $-0.22 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.91M

↓ -17.7% —

Net Income Profit after all expenses

$-27.06M

↓ -162.0% —

FCF / Share Free cash flow per share

$-0.22

↑ +74.2% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF Margin (%)FCF Margin (%) of -148.9% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -36.18x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.16x is weak on an absolute basis (target > 1x)

Health Breakdown

Profitability ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-17.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-321%)	—	—	—	—	—
EPS Growth YoY (%)	80.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—
Net Income Growth YoY (%)	-162.0% Weak Weak Year-over-year change in net income	N/M	N/M	-969.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	74.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-705.9% Weak Weak Year-over-year change in free cash flow	-3672.0% Weak Weak Year-over-year change in free cash flow	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	—	-331.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2308%)	—	—	—	—
Effective Tax Rate (%) (%)	6.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	13.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	57.3% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	—	-292.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2538%)	—	—	—	—
FCF Margin (%) (%)	-148.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-52.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.16x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	—	-2040.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	20.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	123.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-10.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-0.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	-10.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	94.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+529%)	156.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+940%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-36.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	-216.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$623.20K	$1.96M	$-15.42K	$-124.50K	$-4.76K	—
Debt / EBITDA (x)	-0.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.15	$1.64	—	—	—	—
Basic EPS, GAAP (USD)	$-0.92	$-4.79	$0.05	$-0.01	—	—
Free Cash Flow per Share (USD)	$-0.22	$-0.86	$-0.11	$-0.00	—	—
Book Value per Share (USD)	—	—	$-1.81	$-0.02	$-0.00	—
Tangible Book Value per Share (USD)	—	—	$-1.81	$-0.02	$-0.00	—
Basic Weighted Avg Shares (shares)	19.52M	2.15M	7.69M	1.50M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-14.35M	$-1.14M	$-2.02M	$-1.14M	$-702.45K	—
LT Debt (USD)	—	$497.62K	—	—	—	—
Total Equity (USD)	—	—	$-3.91M	$-37.51K	$-2.12K	$1.19K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$2.91M	$3.53M	—	—	—	—
Depreciation Expense (USD)	$7.27K	$5.90K	—	—	—	—
Net Income, GAAP (USD)	$-27.06M	$-10.33M	$403.78K	$-35.39K	$-3.31K	—
Operating Cash Flow (USD)	$-4.33M	$-1.85M	$-818.77K	$-4.24K	$-461.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 19 quarters

OSR Health, Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare OSRH with peers